dupilumab
sanofi,regeneron
['derm']
this is interesting research on the use of #dupliumab in individuals with #atopicdermatitis and 'reported' #foodallergy - however, it's important do discuss the 'finer details'... #aad2023 #aad2023challenge 
FRCPC Internal Medicine - Clinical Immunology & Allergy. Lifelong learner, inspired by those around me! Views are my own.⚕️